Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HRL | FRHC |
|---|---|---|
| Price | $20.08 | $173.49 |
| Change today | ▼ 0.84% | ▲ 0.28% |
| Market cap | $11.05B | $11.07B |
| Return, 3 months | -17.7% | +13.4% |
| Return, year to date | -11.9% | +42.6% |
| Return, 1 year | -13.1% | +3.2% |
| P/E (TTM) | 32.4 | 71.7 |
| P/B | 1.4 | 7.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 5.82% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 34 | 57 |
| 30-day volatility | 34.9% | 45.7% |
| Max drawdown, 1 year | -24.8% | -35.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
